Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang-Xin Fu

Showing results (271-280 of 337) with videos related to

Pageof 34
Sort By:
Nature Immunology|August 28, 2012
Lymphotoxin regulates commensal responses to enable diet-induced obesityVaibhav Upadhyay, Valeriy Poroyko, Tae-jin Kim, et al.
Signal Transduction and Targeted Therapy|June 2, 2026
Targeting tumor-specific T cells with LAG3-directed interleukin-2 prevents T-cell exhaustion and reinvigorates antitumor immunityXiaohong Yu, Huiping Liao, Jiaoyun Lv, et al.
Nature|January 22, 2013
OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3Hongbo Hu, George C Brittain, Jae-Hoon Chang, et al.
Nature Communications|November 4, 2018
Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistanceYong Liang, Haidong Tang, Jingya Guo, et al.
Nature Communications|August 30, 2019
A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8<sup>+</sup> T-cell response and effective tumor controlZhichen Sun, Zhenhua Ren, Kaiting Yang, et al.
Cell Reports|November 9, 2024
TCR-mimicking STAR conveys superior sensitivity over CAR in targeting tumors with low-density neoantigensDaosheng Huang, Yi Li, Wei Rui, et al.
The Journal of Experimental Medicine|January 11, 2007
Induced sensitization of tumor stroma leads to eradication of established cancer by T cellsBin Zhang, Natalie A Bowerman, Joseph K Salama, et al.
Cancer Cell|August 17, 2010
The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunitySaeGwang Park, Zhujun Jiang, Eric D Mortenson, et al.
Nature Communications|September 6, 2022
Lactate increases stemness of CD8 + T cells to augment anti-tumor immunityQiang Feng, Zhida Liu, Xuexin Yu, et al.
Frontiers in Oncology|October 7, 2022
KP372-1-Induced AKT Hyperactivation Blocks DNA Repair to Synergize With PARP Inhibitor Rucaparib <i>via</i> Inhibiting FOXO3a/GADD45α PathwayLingxiang Jiang, Yingchun Liu, Xiaolin Su, et al.
Pageof 34

Showing results (271-280 of 337) with videos related to

Sort By:
Pageof 34
Nature Immunology|August 28, 2012
Lymphotoxin regulates commensal responses to enable diet-induced obesityVaibhav Upadhyay, Valeriy Poroyko, Tae-jin Kim, et al.
Signal Transduction and Targeted Therapy|June 2, 2026
Targeting tumor-specific T cells with LAG3-directed interleukin-2 prevents T-cell exhaustion and reinvigorates antitumor immunityXiaohong Yu, Huiping Liao, Jiaoyun Lv, et al.
Nature|January 22, 2013
OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3Hongbo Hu, George C Brittain, Jae-Hoon Chang, et al.
Nature Communications|November 4, 2018
Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistanceYong Liang, Haidong Tang, Jingya Guo, et al.
Nature Communications|August 30, 2019
A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8<sup>+</sup> T-cell response and effective tumor controlZhichen Sun, Zhenhua Ren, Kaiting Yang, et al.
Cell Reports|November 9, 2024
TCR-mimicking STAR conveys superior sensitivity over CAR in targeting tumors with low-density neoantigensDaosheng Huang, Yi Li, Wei Rui, et al.
The Journal of Experimental Medicine|January 11, 2007
Induced sensitization of tumor stroma leads to eradication of established cancer by T cellsBin Zhang, Natalie A Bowerman, Joseph K Salama, et al.
Cancer Cell|August 17, 2010
The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunitySaeGwang Park, Zhujun Jiang, Eric D Mortenson, et al.
Nature Communications|September 6, 2022
Lactate increases stemness of CD8 + T cells to augment anti-tumor immunityQiang Feng, Zhida Liu, Xuexin Yu, et al.
Frontiers in Oncology|October 7, 2022
KP372-1-Induced AKT Hyperactivation Blocks DNA Repair to Synergize With PARP Inhibitor Rucaparib <i>via</i> Inhibiting FOXO3a/GADD45α PathwayLingxiang Jiang, Yingchun Liu, Xiaolin Su, et al.
Pageof 34